{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:25:46Z","timestamp":1784057146453,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS167"],"award-info":[{"award-number":["DS167"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.mvr.2019.103881","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:34:33Z","timestamp":1557250473000},"page":"103881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity"],"prefix":"10.1016","volume":"125","author":[{"given":"Ma\u0142gorzata","family":"Michalska-Jakubus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2019.103881_bb0005","doi-asserted-by":"crossref","unstructured":"Altorok, N., Wang, Y., Kahaleh, B., 2014. Endothelial dysfunction in systemic sclerosis. Curr. Opin. Rheumatol. 26, 615\u2013620. doi:https:\/\/doi.org\/10.1097\/BOR.0000000000000112.","DOI":"10.1097\/BOR.0000000000000112"},{"key":"10.1016\/j.mvr.2019.103881_bb0010","doi-asserted-by":"crossref","unstructured":"Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G.D., Isner, J.M., 1998. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83, 233\u2013240.","DOI":"10.1161\/01.RES.83.3.233"},{"key":"10.1016\/j.mvr.2019.103881_bb0015","doi-asserted-by":"crossref","unstructured":"Avouac, J., Wipff, J., Goldman, O., Ruiz, B., Couraud, P.O., Chiocchia, G., Kahan, A., Boileau, C., Uzan, G., Allanore, Y., 2008. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum. 58, 3550\u20133561. doi: https:\/\/doi.org\/10.1002\/art.23968.","DOI":"10.1002\/art.23968"},{"key":"10.1016\/j.mvr.2019.103881_bb0020","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mvr.2019.103881_bb0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11892-016-0816-5","article-title":"Targeting Tie2 for treatment of diabetic retinopathy and diabetic macular edema","volume":"16","author":"Campochiaro","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.mvr.2019.103881_bb0030","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.108.169235","article-title":"Disruption of Ang-1\/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice","volume":"28","author":"Chen","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mvr.2019.103881_bb0035","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2003.08.042","article-title":"Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure","volume":"43","author":"Chong","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mvr.2019.103881_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.autrev.2014.12.001","article-title":"Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis","volume":"14","author":"Chora","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.mvr.2019.103881_bb0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrrheum.2015.111","article-title":"Optimized treatment algorithms for digital vasculopathy in systemic sclerosis","volume":"11","author":"Cutolo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00393-004-0673-5","article-title":"Nailfold video-capillaroscopy in systemic sclerosis","volume":"63","author":"Cutolo","year":"2004","journal-title":"Z. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/157339710904140417125010","article-title":"Early diagnostic and predictive value of capillaroscopy in systemic sclerosis","volume":"9","author":"Cutolo","year":"2013","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.mvr.2019.103881_bb0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/kex460","article-title":"Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases","volume":"57","author":"Cutolo","year":"2018","journal-title":"Rheumatol.(Oxford)."},{"key":"10.1016\/j.mvr.2019.103881_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1747.1998.00262.x","article-title":"Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice","volume":"111","author":"Detmar","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0075","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0080","first-page":"149","article-title":"Angiogenic and angiostatic factors in the molecular control of angiogenesis","volume":"47","author":"Distler","year":"2003","journal-title":"Q. J. Nucl. Med."},{"key":"10.1016\/j.mvr.2019.103881_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.mvr.2019.103881_bb0090","first-page":"iii26","article-title":"Angiogenesis and vasculogenesis in systemic sclerosis","volume":"45","author":"Distler","year":"2006","journal-title":"Rheumatol. (Oxford)."},{"key":"10.1016\/j.mvr.2019.103881_bb0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-012-2378-4","article-title":"Circulating angiopoietin and Tie-2 levels in systemic sclerosis","volume":"33","author":"Dunne","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.mvr.2019.103881_bb0100","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mvr.2019.103881_bb0105","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.yexcr.2013.03.011","article-title":"Angiopoietin signaling in the vasculature","volume":"319","author":"Eklund","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mvr.2019.103881_bb0115","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mvr.2019.103881_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rdc.2008.01.001","article-title":"The pathology of scleroderma vascular disease","volume":"34","author":"Fleming","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.mvr.2019.103881_bb0125","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3899\/jrheum.111380","article-title":"Vascular leak is a central feature in the pathogenesis of systemic sclerosis","volume":"39","author":"Frech","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2133.1992.tb00100.x","article-title":"Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy","volume":"126","author":"Freemont","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mvr.2015.03.005","article-title":"Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: clinical and prognostic implications","volume":"99","author":"Ghizzoni","year":"2015","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0145","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mvr.2019.103881_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/mvre.2002.2421","article-title":"Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells","volume":"64","author":"Harfouche","year":"2002","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/mvre.1999.2179","article-title":"Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells","volume":"58","author":"Hayes","year":"1999","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0160","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science."},{"key":"10.1016\/j.mvr.2019.103881_bb0165","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","article-title":"New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF","volume":"18","author":"Holash","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mvr.2019.103881_bb0170","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3748\/wjg.v10.i4.463","article-title":"Roles of main pro- and anti-angiogenic factors in tumor angiogenesis","volume":"10","author":"Huang","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mvr.2019.103881_bb0175","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0002-9440(10)61115-7","article-title":"Suppression of diabetic retinopathy with angiopoietin-1","volume":"160","author":"Joussen","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mvr.2019.103881_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rdc.2007.12.004","article-title":"Vascular disease in scleroderma: mechanisms of vascular injury","volume":"34","author":"Kahaleh","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.mvr.2019.103881_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","article-title":"Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase\/Akt signal transduction pathway","volume":"86","author":"Kim","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.RES.86.9.952","article-title":"Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion","volume":"86","author":"Kim","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/hh1801.097034","article-title":"Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression","volume":"89","author":"Kim","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0960-9822(98)70205-2","article-title":"Angiopoietin-1 induces sprouting angiogenesis in vitro","volume":"8","author":"Koblizek","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mvr.2019.103881_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2012.10.010","article-title":"Orchestral actions of angiopoietin-1 in vascular regeneration","volume":"19","author":"Koh","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mvr.2019.103881_bb0210","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2008.094664","article-title":"The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus","volume":"68","author":"K\u00fcmpers","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.mvr.2019.103881_bb0215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mvr.2019.103881_bb0220","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.CIR.0000138112.90641.7F","article-title":"Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor Tie-2, and vascular endothelial growth factor levels in acute coronary syndromes","volume":"110","author":"Lee","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2019.103881_bb0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1593\/neo.06109","article-title":"Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth","volume":"8","author":"Lee","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.mvr.2019.103881_bb0230","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.2337\/diacare.27.12.2918","article-title":"Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention","volume":"27","author":"Lim","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mvr.2019.103881_bb0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.11.004","article-title":"Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage\/dysfunction and atherosclerosis","volume":"180","author":"Lim","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mvr.2019.103881_bb0240","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pros.20163","article-title":"Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer","volume":"62","author":"Lind","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.mvr.2019.103881_bb0245","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/bjo.2004.048587","article-title":"Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade","volume":"88","author":"Lip","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mvr.2019.103881_bb0250","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mvr.2019.103881_bb0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0945-053X(01)00149-4","article-title":"Angiopoietin and Tie signaling pathways in vascular development","volume":"20","author":"Loughna","year":"2001","journal-title":"Matrix Biol."},{"key":"10.1016\/j.mvr.2019.103881_bb0260","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1755-3768.2012.02473.x","article-title":"Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGF\u03b21 in diabetic eyes undergoing vitrectomy","volume":"91","author":"Loukovaara","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mvr.2019.103881_bb0265","first-page":"641","article-title":"Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin","volume":"20","author":"Mackiewicz","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mvr.2019.103881_bb0275","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.RES.83.8.852","article-title":"Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia","volume":"83","author":"Mandriota","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0280","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","article-title":"Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis","volume":"14","author":"Manetti","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.mvr.2019.103881_bb0285","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0290","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2012-203183","article-title":"Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis","volume":"72","author":"Manetti","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.mvr.2019.103881_bb0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13075-016-0937-x","article-title":"The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?","volume":"18","author":"Manetti","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mvr.2019.103881_bb0300","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2019.103881_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-017-1370-5","article-title":"The \"myth\" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?","volume":"19","author":"Matucci-Cerinic","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mvr.2019.103881_bb0310","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/keq392","article-title":"Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease","volume":"50","author":"Michalska-Jakubus","year":"2011","journal-title":"Rheumatol. (Oxford)."},{"key":"10.1016\/j.mvr.2019.103881_bb0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mvr.2016.11.006","article-title":"Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis","volume":"110","author":"Michalska-Jakubus","year":"2017","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1346-8138.2011.01322.x","article-title":"Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations","volume":"39","author":"Moneib","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.rdc.2007.12.006","article-title":"Vascular disease in scleroderma: angiogenesis and vascular repair","volume":"34","author":"Mulligan-Kehoe","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.mvr.2019.103881_bb0330","doi-asserted-by":"crossref","first-page":"15732","DOI":"10.1074\/jbc.274.22.15732","article-title":"Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells","volume":"274","author":"Oh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2019.103881_bb0335","first-page":"213","article-title":"Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors","volume":"79","author":"Papapetropoulos","year":"1999","journal-title":"Lab. Investig."},{"key":"10.1016\/j.mvr.2019.103881_bb0340","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1074\/jbc.275.13.9102","article-title":"Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt\/survivin pathway","volume":"275","author":"Papapetropoulos","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mvr.2019.103881_bb0345","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bjo.2004.049940","article-title":"Angiopoietin concentrations in diabetic retinopathy","volume":"89","author":"Patel","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mvr.2019.103881_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/rp.59.1.51","article-title":"Functional significance of Tie2 signaling in the adult vasculature","volume":"59","author":"Peters","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0355","first-page":"19","article-title":"Alterations of angiopoietin 1 and 2 expression in diabetic retinopathy","volume":"50","author":"Rangasamy","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mvr.2019.103881_bb0360","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCRESAHA.106.143594","article-title":"Angiopoietin-2 impairs revascularization after limb ischemia","volume":"101","author":"Reiss","year":"2007","journal-title":"Circ. Res."},{"issue":"Suppl. 65","key":"10.1016\/j.mvr.2019.103881_bb0365","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0370","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1242\/jcs.108.6.2369","article-title":"Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor","volume":"108","author":"Roberts","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mvr.2019.103881_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mvr.2019.103881_bb0380","first-page":"21","article-title":"Targeting tie-2 in patients with wet AMD or diabetic eye disease could allow clinicians to treat patients who have not responded to conventional therapies","author":"Shapiro","year":"2017","journal-title":"Retina Today"},{"key":"10.1016\/j.mvr.2019.103881_bb0385","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/micc.12281","article-title":"Nailfold capillaroscopy and clinical applications in systemic sclerosis","volume":"23","author":"Smith","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/j.mvr.2019.103881_bb0390","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kev441","article-title":"An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases","volume":"55","author":"Smith","year":"2016","journal-title":"Rheumatol. (Oxford)."},{"key":"10.1016\/j.mvr.2019.103881_bb0395","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/rheumatology\/kep154","article-title":"The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis","volume":"48","author":"Solanilla","year":"2009","journal-title":"Rheumatol. (Oxford)."},{"key":"10.1016\/j.mvr.2019.103881_bb0400","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2019.103881_bb0405","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mvr.2019.103881_bb0410","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.282.5388.468","article-title":"Increased vascularization in mice overexpressing angiopoietin-1","volume":"282","author":"Suri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.mvr.2019.103881_bb0415","first-page":"15","article-title":"Evaluation of serum vascular endothelial growth factor and endostatin in systemic sclerosis patients \u2013 correlation with lung and cardio-vascular system involvement","volume":"29","author":"Sysa-J\u0119drzejowska","year":"2004","journal-title":"Centr. Eur. J. Immunol."},{"key":"10.1016\/j.mvr.2019.103881_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1618","article-title":"Angiopoietins in tumours: the angiogenic switch","volume":"204","author":"Tait","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.mvr.2019.103881_bb0425","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/s10165-012-0755-1","article-title":"Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis","volume":"23","author":"Takahashi","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.mvr.2019.103881_bb0430","first-page":"7124","article-title":"Expression of angiopoietins and its clinical significance in non-small cell lung cancer","volume":"62","author":"Tanaka","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0435","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1469-7580.2002.00061.x","article-title":"Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage","volume":"200","author":"Thurston","year":"2002","journal-title":"J. Anat."},{"key":"10.1016\/j.mvr.2019.103881_bb0440","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00441-003-0749-6","article-title":"Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis","volume":"314","author":"Thurston","year":"2003","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.mvr.2019.103881_bb0445","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.mvr.2019.103881_bb0450","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.mvr.2019.103881_bb0455","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ajo.2004.10.004","article-title":"Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy","volume":"139","author":"Watanabe","year":"2005","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.mvr.2019.103881_bb0460","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00535-002-1078-3","article-title":"Expression of Tie-2 and angiopoietin-1 and -2 in early phase of ulcer healing","volume":"38","author":"Wen","year":"2003","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.mvr.2019.103881_bb0465","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9440(10)63998-3","article-title":"Angiopoietin-2 is implicated in the regulation of tumor angiogenesis","volume":"158","author":"Yu","year":"2001","journal-title":"Am. J. Pathol."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286218302619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286218302619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T13:46:10Z","timestamp":1663422370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286218302619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":93,"alternative-id":["S0026286218302619"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2019.103881","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2019.103881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103881"}}